Keratosis Clinical Trials

1 recruiting

Keratosis Trials at a Glance

18 actively recruiting trials for keratosis are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in New Brighton, Portland, and Memphis. Lead sponsors running keratosis studies include St. Jude Children's Research Hospital, Sun Pharmaceutical Industries, Inc., and DermBiont, Inc..

Browse keratosis trials by phase

Treatments under study

About Keratosis Clinical Trials

Looking for clinical trials for Keratosis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Keratosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Keratosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Familial Investigations of Childhood Cancer Predisposition

Hereditary Breast and Ovarian CancerHodgkin LymphomaAdrenocortical Carcinoma+30 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting
Phase 3

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Actinic Keratosis
Sun Pharmaceutical Industries, Inc.160 enrolled10 locationsNCT07144345
Recruiting
Phase 3

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

Actinic Keratosis
Sun Pharmaceutical Industries, Inc.260 enrolled20 locationsNCT07144852
Recruiting
Phase 1

Nucleoside Therapy in Patients With Telomere Biology Disorders

Dyskeratosis CongenitaTelomere Biology DisordersRevesz Syndrome
Suneet Agarwal36 enrolled1 locationNCT06817590
Recruiting
Phase 2

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Dyskeratosis CongenitaFanconi AnemiaMyelodysplastic Syndromes+5 more
Masonic Cancer Center, University of Minnesota48 enrolled1 locationNCT03579875
Recruiting
Phase 1Phase 2

Evaluate RLS-1496 Topical Cream for Actinic Keratosis

Actinic Keratosis (AK)
Rubedo Life Sciences, Inc.24 enrolled4 locationsNCT07340697
Recruiting
Not Applicable

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Actinic Keratosis (AK)
Cosmetique Active International80 enrolled1 locationNCT07335003
Recruiting
Phase 1

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Actinic Keratosis (AK)
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.40 enrolled1 locationNCT07318675
Recruiting
Phase 2

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

Photodynamic TherapyActinic KeratosisImipramine
VA Office of Research and Development48 enrolled1 locationNCT06778434
Recruiting
Not Applicable

Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris

Keratosis Pilaris (KP)
Johns Hopkins University25 enrolled1 locationNCT07078461
Recruiting
Phase 2

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Dyskeratosis CongenitaFanconi AnemiaBone Marrow Failure+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins27 enrolled1 locationNCT04232085
Recruiting

Investigation of the Genetics of Hematologic Diseases

Diamond-Blackfan AnemiaDyskeratosis CongenitaFanconi Anemia+10 more
St. Jude Children's Research Hospital1,716 enrolled1 locationNCT02720679
Recruiting
Phase 3

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Actinic Keratosis of Face and Scalp
Aresus Pharma GmbH280 enrolled1 locationNCT07137819
Recruiting

Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns

Actinic Keratosis (AK)
Thomas Dirschka20 enrolled1 locationNCT06648447
Recruiting

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

SmokingSmoking, TobaccoSmoking, Cigarette+5 more
Memorial Sloan Kettering Cancer Center5,122 enrolled1 locationNCT06535867
Recruiting
Phase 2

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

Seborrheic Keratosis
DermBiont, Inc.60 enrolled4 locationsNCT06108024
Recruiting
Phase 1

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Photodynamic TherapyActinic KeratosisImipramine
Wright State University24 enrolled1 locationNCT05688904
Recruiting

Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors

Eyelid TumorXanthelasma PalpebrarumPigmented Nevi+1 more
Sun Yat-sen University1,000 enrolled1 locationNCT06206681